# US 2018/0022808 A1 · Antibody construct

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0022808 A1
- Document ID: US20180022808A1
- Status: Published application
- Kind: A1
- Application number: 15/550,073
- Filed: 2016-02-10
- Published: 2018-01-25
- Earliest claimed: 2015-02-10
- Assignees: Medizinische Universität Wien
- Applicants: Medizinische UniversitäT Wien
- Inventors: Christoph Madritsch; Sabine Flicker; Rudolf Valenta; Elisabeth Gader-Maier; Julia Eckl-Dorna; Verena Niederberger; Katharina Blatt; Peter Valent; Isabella Ellinger
- Web page: https://patentgrep.com/patent/US20180022808A1

## CPC

- C07K 16/2821: {against ICAM molecules, e.g. CD50, CD54, CD102}
- A61K 39/395: Antibodies (agglutinins A61K38/36 {; as drug carriers A61K47/50}); Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C07K 16/16: against material from plants
- C07K 16/46: Hybrid immunoglobulins (hybrids of an immunoglobulin with a peptide not being an immunoglobulin C07K19/00)
- C07K 2317/31: multispecific
- C07K 2317/55: Fab or Fab'
- C07K 2317/70: characterized by effect upon binding to a cell or to an antigen
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to an antibody construct comprising at least one antigen binding site specific for ICAM1 and at least one antigen binding site specific for at least one allergen.

## Claims

### Claim 1

An antibody construct comprising at least one antigen binding site specific for ICAM1 and at least one antigen binding site specific for at least one allergen.

### Claim 2 (depends on 1)

The antibody construct of claim 1, wherein the antibody construct is a complex, conjugate or fusion protein comprising an antigen binding site specific for ICAM1 and an antigen binding site specific for an allergen.

### Claim 3 (depends on 1)

The antibody construct of claim 1 comprising an antigen binding site specific for ICAM1 chemically cross-linked to an antigen binding site specific for an allergen.

### Claim 4 (depends on 1)

The antibody construct of claim 1, wherein the antibody construct is a bispecific antibody, a bispecific diabody or a bispecific (Fab)2 fragment.

### Claim 5 (depends on 1)

The antibody construct of claim 1, wherein the allergen is an inhalation or food allergen.

### Claim 6 (depends on 5)

The antibody construct of claim 5, wherein the inhalation allergen is selected from the group consisting of pollen allergens, mold allergens, mite allergens and animal allergens, preferably pet allergens.

### Claim 7 (depends on 1)

The antibody construct of claim 1, wherein the allergen is selected from the group consisting of a pollen allergen, mite allergen, cat allergen, dog allergen, insect bite/sting allergen, legume allergen, fruit allergen, nut allergen, milk allergen and fish allergen.

### Claim 8 (depends on 1)

The antibody construct of claim 1, wherein the allergen is a pollen allergen selected from the group of a grass pollen allergen, preferably the grass pollen allergen Phl p 1, Phl p 2, Phl p 4, Phl p 5, Phl p 6, Phl p 7, Phl p 11, Phl p 12 or Phl p 13, a weed allergen, preferably the ragweed allergen Amb a 1, Amb a 2, Amb a 3, Amb a 4, Amb a 5, Amb a 6, Amb a 7, Amb a 8, Amb a 9 or Amb a 10, a mugwort allergen, preferably Art v 1, Art v 2, Art v 3, Art v 4, Art v 5 or Art v 6, a Paritaria pollen allergen, preferably Par j 1, Par j 2, Par j 3 or Par j 4, a olive pollen allergen, preferably Ole e 1, Ole e 2, Ole e 3, Ole e 4, Ole e 5, Ole e 6, Ole e 7, Ole e 8, Ole e 9, Ole e 10 or Ole e 11, a pollen allergen from Saltwort thistle, preferably Sal k 1, Sal k 2, Sal k 3, Sal k 4 or Sal k 5, and a tree pollen, preferably a Cypress pollen, preferably Cha o 1 or Cha o 2, or a cedar pollen, preferably Jun a 1, Jun a 2 or Jun a 3, or a birch pollen allergen, preferably Bet v 1.

### Claim 9 (depends on 1)

The antibody construct of claim 1, wherein the allergen is Phl p 2 or Phl p 5.

### Claim 10 (depends on 1)

The antibody construct of claim 1, wherein the allergen is a mite allergen, preferably Der p 1, Der p 2, Der p 3, Der p 4, Der p 5, Der p 6, Der p 7, Der p 8, Der p 9, Der p 10, Der p 11, Der p 14, Der p 15, Der p 18, Der p 20, Der p 21 and Der p 23.

### Claim 11 (depends on 1)

The antibody construct of claim 1, wherein the allergen is an animal, preferably pet allergen, selected from a group consisting of a cat allergen, preferably Fel d 1, Fel d 2, Fel d 3, Fel d 4, Fel d 5, Fel d 6, Fel d 7 and Fel d 8, a dog allergen, preferably Can f 1, Can f 2, Can f 3, Can f 4 and Can f 5, and a cockroach allergen, preferably Bla g 1, Bla g 2, Bla g 3, Bla g 4, Bla g 5, Blag 6, Blag 7, Bla g 8, Bla g 11, Per a 1, Per a 2, Per a 3, Per a 4, Per a 5, Per a 6, Per a 7, Per a 9 and Per a 10.

### Claim 12 (depends on 1)

The antibody construct of claim 1, wherein the antibody construct comprises at least one immunoglobulin or at least one immunoglobulin fragment comprising an antigen binding site for ICAM1 and at least one immunoglobulin or at least one immunoglobulin fragment comprising an antigen binding site for at least one allergen.

### Claim 13 (depends on 1)

A pharmaceutical composition comprising the antibody construct of claim 1.

### Claim 14 (depends on 13)

The pharmaceutical composition of claim 13, wherein the composition is adapted for intranasal, oral or ocular administration or for inhalation.

### Claim 15 (depends on 13)

The pharmaceutical composition of claim 13 for the use of treating and/or preventing an allergy.

### Claim 16 (depends on 13)

The pharmaceutical composition of claim 13 for the use of preventing, reducing and/or alleviating allergic symptoms in a patient.

### Claim 17 (depends on 15)

The pharmaceutical composition for the use of claim 15, wherein the pharmaceutical composition is administered by inhalation.
